From: The role of soluble CD80 in patients with soft tissue tumors
Characteristic in STS patients | N (85) | sCD80 median | p value | |
---|---|---|---|---|
Sex | Male | 45 | 495.4 | *0.604 |
Female | 40 | 474.8 | ||
Age | < 60y | 29 | 320.9 | *0.00244 |
> 60y | 56 | 526.9 | ||
Tumor size | < 10 cm | 42 | 486.5 | *0.93 |
> 10 cm | 43 | 474.8 | ||
Location | Extremity | 61 | 452.3 | *0.095 |
Trunk | 24 | 639 | ||
Tumor depth | Superficial | 13 | 531.1 | *0.132 |
Deep | 72 | 469.6 | ||
Histological grade | Low grade | 26 | 431.2 | *0.292 |
High grade | 59 | 496.4 | ||
Stage | I | 26 | 431.2 | #0.541 |
II | 15 | 496.4 | ||
III | 44 | 508.6 | ||
Treatment | Wide resection | 57 | 494.5 | #0.253 |
Marginal resection | 23 | 381.9 | ||
Intralesional resection | 3 | 592.1 | ||
Ion beam radiotherapy | 2 | 382.1 | ||
Chemotherapy | - | 59 | 497.3 | *0.198 |
+ | 26 | 451.3 | ||
Radiotherapy | - | 64 | 463.5 | *0.439 |
+ | 21 | 562.1 | ||
History of other malignant tumors | - | 66 | 457.4 | *0.056 |
+ | 19 | 562.1 |